Slow-release ketamine pills might offer a new treatment path, stopping relapse, and allowing home use, potentially revolutionizing care for depression patients.
In a novel phase 2 trial, patients taking slow-release ketamine tablets showed reduced relapse rates compared to those on a placebo, indicating promising results for future depression treatments.
Collection
[
|
...
]